Lower exposure and faster clearance of bevacizumab in gastric cancer and the impact of patient variables: analysis of individual data from AVAGAST phase III trial.
AAPS J
; 16(5): 1056-63, 2014 Sep.
Article
in En
| MEDLINE
| ID: mdl-24942210
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Stomach Neoplasms
/
Adenocarcinoma
/
Antineoplastic Combined Chemotherapy Protocols
/
Angiogenesis Inhibitors
/
Antibodies, Monoclonal, Humanized
Type of study:
Prognostic_studies
Limits:
Aged80
Language:
En
Journal:
AAPS J
Journal subject:
FARMACOLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2014
Document type:
Article